Journal of Drugs in Dermatology

View more issues:

Articles in Nov, 2007 issue of Journal of Drugs in Dermatology

• Upcoming dermatology meetings
• Nanotechnology
  by Macrene Alexiades-Armenakas
• Treatment of alopecia areata of the scalp with intradermal injections of botulinum toxin
• A randomized trial to evaluate the suppressive effect of high-dose acyclovir versus valacyclovir on persons with HSV-2
• Nonablative skin tightening with a variable depth heating 1310-nm wavelength laser in combination with surface cooling
  by Macrene Alexiades-Armenakas
• IL-2 and metastatic melanoma
  by Marissa Heller
• PSUNRISE—prospective study using Remicade in psoriasis patients with an inadequate response to etanercept
• Lovastatin in treating patients at high risk of recurrent melanoma
• Orphan Drug Designation for ALS-357
  by Marissa Heller
• Efficacy of therapy with the spironolactone pills compared to minoxidil lotion in female pattern hair loss
• Botanical ingredients in cosmeceuticals
  by Leslie Baumann
• Study of a Bupivacaine patch to treat postherpetic neuralgia
• Fractionated delivery systems for difficult to treat clinical applications: acne scarring, melasma, atrophic scarring, striae distensae, and deep rhytides
  by Amy F. Taub
• A phase II study of ASC-J9 cream in acne vulgaris
• Efficacy and safety of cyclosporine a microemulsion in maintenance patients with chronic plaque psoriasis
• Topical tazarotene in treating patients with basal cell skin cancer and basal cell nevus syndrome
• The yin and yang of cathelicidins: how the innate immune system drives skin disease
  by Kendra Gail Bergstrom
• A study to assess the efficacy and safety of dutasteride 0.5 mg once daily for 6 months in the treatment of male subjects with androgenetic alopecia
• Safety, pharmacokinetics, and efficacy study of NB-001 to treat recurrent herpes labialis
• Plasma skin regeneration technology
  by Melissa A. Bogle
• Second-generation smallpox vaccine
  by Marissa Heller
• Study of the safety and effectiveness of CNTO 1275 compared to etanercept for the treatment of moderate to severe plaque psoriasis
• Photodynamic therapy using silicon phthalocyanine 4 in treating patients with actinic keratosis, Bowen's disease, skin cancer, or stage I or stage II mycosis fungoides
• Generic Famvir® tablets approved
  by Marissa Heller
• Imiquimod in children with plaque morphea
• Photodynamic therapy in treating patients with skin cancer
• Use of topical lidocaine for cosmetic dermatologic procedures
  by Divya Railan
• Letter from the guest editor
  by Macrene Alexiades-Armenakas
• NGX-4010 and postherpetic neuralgia
  by Marissa Heller
• Single-blind study determining the efficacy of polypodium leucotomos extract supplement in decreasing UVA premutagenic and photoaging markers
• Treatment of photoaging with a very superficial Er:YAG laser in combination with a broadband light source
  by Alexander L. Berlin
• Botulinum toxin type a enhances the outcome of fractional resurfacing of the cheek
  by Kenneth Beer
• Comparison efficacy of azithromycin with doxycycline in the treatment of acne vulgaris
• Psoriasis longitudinal assessment and registry
• A study with ASP2151 in subjects with recurrent episodes of genital herpes
• Juvederm: a hyaluronic acid dermal filler
  by Gary D. Monheit
• Microcyn® Technology for diabetic foot ulcers
  by Marissa Heller
• A study to evaluate psoriasis outcomes and safety events in patients with chronic moderate to severe plaque psoriasis
• Evaluating the efficacy in improving facial photodamage with a mixture of topical antioxidants
  by Jessica Hsu
• Photodynamic therapy update 2007
  by Michael H. Gold